Anti‐EpCAM treatment like EpAb2‐6 could induce apoptosis in colorectal tumor cells,35 and its combination with atezolizumab, an anti‐PD‐L1 antibody, enhances the cytotoxic activity of CD8+ T cells.34 This evidence concerns the gene CD8A and colorectal neoplasm.